Cargando…
Altered p16(INK4) and RB1 Expressions Are Associated with Poor Prognosis in Patients with Nonsmall Cell Lung Cancer
p16(INK4) and RB1 are two potent cell cycle regulators to control the G1/S transition by interacting with CDK4/6, E2F, and D-type cyclins, respectively. Depending on the tumour type, genetic alterations resulting in the functional inactivation have frequently been reported in both genes. By contrast...
Autores principales: | Zhao, Weiqiang, Huang, Cheng C., Otterson, Gregory A., Leon, Marino E., Tang, Yan, Shilo, Konstantin, Villalona, Miguel A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3350860/ https://www.ncbi.nlm.nih.gov/pubmed/22619677 http://dx.doi.org/10.1155/2012/957437 |
Ejemplares similares
-
Clinical and Metabolic Parameters in Non-Small Cell Lung Carcinoma and Colorectal Cancer Patients with and without KRAS Mutations
por: Yilmaz, Ahmet, et al.
Publicado: (2014) -
Cellular localization of protein arginine methyltransferase-5 correlates with grade of lung tumors
por: Shilo, Konstantin, et al.
Publicado: (2013) -
Increased NQO1 but Not c-MET and Survivin Expression in Non-Small Cell Lung Carcinoma with KRAS Mutations
por: Yilmaz, Ahmet, et al.
Publicado: (2014) -
Metastatic Squamous Cell Carcinoma Component from an Adenosquamous Carcinoma of the Lung with Identical Epidermal Growth Factor Receptor Mutations
por: Burkart, Jarred, et al.
Publicado: (2015) -
P16(INK4A) expression might be associated with a favorable prognosis for cervical adenocarcinoma via dysregulation of the RB pathway
por: Ishikawa, Masako, et al.
Publicado: (2021)